We are live on ! Find out more
NC

NinePointTwo Capital Portfolio holdings

AUM $252M
1-Year Est. Return 12.98%
This Fund
S&P 500
This Quarter Est. Return
-2.29%
1 Year Est. Return
+12.98%
3 Year Est. Return
+1.62%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$245M
AUM Growth
-$13M
Cap. Flow
-$4.91M
Cap. Flow %
-2%
Top 10 Hldgs %
68.82%
Holding
343
New
104
Increased
9
Reduced
33
Closed
96

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$443K
2
ACN icon
Accenture
ACN
+$427K
3
SBH icon
Sally Beauty Holdings
SBH
+$334K
4
GT icon
Goodyear
GT
+$333K
5
BNY
Bank of New York Mellon
BNY
+$326K

Top Sells

Rank Stock Value
1
SCHP icon
Schwab US TIPS ETF
SCHP
+$3M
2
EMLC icon
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
+$1.58M
3
PDBC icon
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
+$1.36M
4
HYLB icon
Xtrackers USD High Yield Corporate Bond ETF
HYLB
+$1.1M
5
MINT icon
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
+$958K

Sector Composition

Rank Sector Weight
1 Technology 9.27%
2 Healthcare 5.9%
3 Financials 4.36%
4 Consumer Discretionary 3.27%
5 Industrials 3.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRUP icon
326
Trupanion
TRUP
$1.05B
– –
-12,659
Closed -$249K
TXG icon
327
10x Genomics
TXG
$5.87B
– –
-4,881
Closed -$272K
TXT icon
328
Textron
TXT
$16.6B
– –
-3,765
Closed -$254K
VCYT icon
329
Veracyte
VCYT
$4.52B
– –
-10,437
Closed -$265K
VKTX icon
330
Viking Therapeutics
VKTX
$4.04B
– –
-11,201
Closed -$181K
VTYX
331
DELISTED
Ventyx Biosciences
VTYX
– –
-7,741
Closed -$253K
WOR icon
332
Worthington Enterprises
WOR
$2.76B
– –
-6,091
Closed -$260K
XPOF icon
333
Xponential Fitness
XPOF
$265M
– –
-10,349
Closed -$178K
ZNTL icon
334
Zentalis Pharmaceuticals
ZNTL
$308M
– –
-10,716
Closed -$302K
RVNC
335
DELISTED
Revance Therapeutics, Inc.
RVNC
– –
-8,444
Closed -$213K
AXNX
336
DELISTED
Axonics, Inc. Common Stock
AXNX
– –
-5,479
Closed -$276K
CERE
337
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
– –
-8,151
Closed -$259K
MRTX
338
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-6,652
Closed -$240K
SCPL
339
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
– –
-13,205
Closed -$259K
RETA
340
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-2,868
Closed -$292K
NEX
341
DELISTED
NexTier Oilfield Solutions Inc.
NEX
– –
-20,439
Closed -$182K
ISEE
342
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-6,925
Closed -$272K
ABB
343
DELISTED
ABB Ltd
ABB
– –
-5,384
Closed -$211K
10 11 12 13
14

Similar funds

LWM
Ledge Wealth Management Sartell, Minnesota $257M AUM 13.95% 1-Year Est. Return
LWA
LWS Wealth Advisors Basking Ridge, New Jersey $266M AUM 12.97% 1-Year Est. Return
WMC
Westwood Management Corporation Chicago, Illinois $270M AUM 54.59% 1-Year Est. Return
SRAM
Spouting Rock Asset Management Bryn Mawr, Pennsylvania $273M AUM 46.69% 1-Year Est. Return
EWMCB
EisnerAmper Wealth Management Corporate Benefits Iselin, New Jersey $274M AUM 12.56% 1-Year Est. Return
LFA
Landmark Financial Advisors Bowling Green, Kentucky $278M AUM 11.67% 1-Year Est. Return
CT
Columbia Trust Portland, Oregon $221M AUM 25.72% 1-Year Est. Return
DE
Day & Ennis Macon, Georgia $283M AUM 13.32% 1-Year Est. Return

NinePointTwo Capital's Q3 2023 Portfolio in Review

As of Q3 2023, NinePointTwo Capital held 343 positions worth $245M, down 5% from $258M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

NinePointTwo Capital's Q3 2023 filing shows 104 new, 9 increased, 33 reduced and 96 closed positions. Its largest new stake was Lam Research: 6,750 shares worth $423K. The largest sale was Schwab US TIPS ETF, an estimated $3M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, up from 7.9% a quarter earlier, followed by Healthcare and Financials.

  • NinePointTwo Capital's largest Q3 2023 buy was Lam Research: 6,750 shares worth $423K.
  • NinePointTwo Capital added most to Adobe in Q3 2023, an estimated $275K increase.
  • NinePointTwo Capital's biggest Q3 2023 reduction was Schwab US TIPS ETF, cutting an estimated $3M.
  • NinePointTwo Capital fully exited Carvana in Q3 2023, selling an estimated $472K.
  • NinePointTwo Capital's ten largest holdings make up 69% of its $245M portfolio in Q3 2023.
  • NinePointTwo Capital opened 104 new positions and closed 96 in Q3 2023.
  • NinePointTwo Capital's portfolio value fell 5% quarter-over-quarter to $245M.

Based on NinePointTwo Capital's 13F filing for Q3 2023, filed 14 Nov 2023.